Xencor | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
AbbVie USD 4.81B 1.54B 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
Amgen USD 3.38B 111M 2024-12
Arrowhead Research USD -175115000 2.32M 2024-12
AstraZeneca USD 1.67B 162M 2024-12
Biogen USD 572.2M 118.5M 2024-12
Bristol-Myers Squibb USD 4.26B 226M 2024-12
Cytokinetics USD -150020000 10.52M 2024-12
GlaxoSmithKline GBP 563M 2.08B 2024-12
J&J USD 5.42B 1.86B 2024-12
MacroGenics USD 56.31M 111.97M 2024-09
Merck USD 5.22B 114M 2024-12
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
Xencor USD -52626000 6.33M 2024-12



Xencor L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.